Therapeutic Discovery Project Defending America's Competitiveness in Biotechnology

Type:

Video

Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.

April 8, 2011 John Sterling, editor-in-chief of Genetic Engineering and Biotechnology News (GEN)	April 7, 2011 Countdown to Partnering With John Carroll from Fierce Biotech	March 29, 2011 Derek Gregg, Chair of BioWV and Chief Executive Officer of Vandalia Research	March 4, 2011 Dr. Lisa Beth Ferstenberg, Founding CEO of Cellective Therapeutics and a serial entrepreneur
December 8, 2010 Intellectual Property in Emerging Markets	July 29, 2010 DOE’s Assistant Secretary Zoi Announces Funding of $24 million Research Groups	June 23, 2010 BioBytes: The Biotech Drug Delivery Timeline	June 15, 2010 BioBytes: Biotechnology and Diagnostic Tools